Search by indication

ANTI-GOUT

ALLOPURINOL

ALUPRIN
100 mg Tablet

Treatment of gout either primary or secondary to the hyperuricemia associated with blood dyscrasias and their therapy, primary or secondary uric acid nephropathy…

READ MORE

ALLOPURINOL

300 mg Tablet

Treatment of gout either primary or secondary to the hyperuricemia associated with blood dyscrasias and their therapy, primary or secondary uric acid nephropathy…

READ MORE

SITE MAP

Home

About

Products

Services

Careers

Privacy Policy

Contact Us

(02) 8556 79-65 / (02) 8556-79-66

customer.service@drugmakers.com.ph

© 2019 Drugmaker’s Laboratories, Inc. All rights reserved.
Trademarks are owned by or licensed to the DMLI group of companies.
Drugmaker’s Laboratories, Inc. Registered in Philippines.

Registered office: E&E Industrial Complex, Narra Rd., Brgy. San Antonio, San Pedro, Laguna

 

ALLOPURINOL

300 mg Tablet

Treatment of gout either primary or secondary to the hyperuricemia associated with blood dyscrasias and their therapy. Primary or secondary uric acid nephropathy, with or without accompanying symptoms of gout, recurrent uric stone formation. Prophylactic treatment to tissue deposition, renal calculi or uric acid nephropathy in patients with leukemia, lymphomas and malignancies who are receiving cancer chemotherapy with its resultant elevating effect on serum uric acid levels.

ALLOPURINOL

ALUPRIN
100 mg Tablet

Treatment of gout either primary or secondary to the hyperuricemia associated with blood dyscrasias and their therapy, primary or secondary uric acid nephropathy with or without accompanying symptoms of gout; recurrent uric acid stone formation. Prophylactic treatment to prevent tissue deposition, renal calculi or uric acid nephropathy in patients with leukemias lymphomas and malignancies who are receiving cancer chemotherapy with its resultant elevating effect on serum uric acid levels.